Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Primary Purpose
Substance-Related Disorders
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Behavior Therapy
Sponsored by
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring substance use disorders
Eligibility Criteria
Inclusion Criteria: Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment Exclusion Criteria: Unable to give informed consent (fails simple consent quiz) Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?
Sites / Locations
- Aegis Medical Systems, Inc.
- Oasis Clinic
- Glenwood Life Counseling Center
- Lower Eastside Service Center (LESC)
- Greenwich House, Inc.
- ACT
- Charleston Center
Outcomes
Primary Outcome Measures
ASI
Opioid and cocaine use
AIDS risk behavior
Secondary Outcome Measures
Full Information
NCT ID
NCT00033020
First Posted
April 5, 2002
Last Updated
January 11, 2017
Sponsor
Johns Hopkins University
1. Study Identification
Unique Protocol Identification Number
NCT00033020
Brief Title
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
Official Title
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Study Type
Interventional
2. Study Status
Record Verification Date
April 2010
Overall Recruitment Status
Completed
Study Start Date
April 2001 (undefined)
Primary Completion Date
February 2003 (Actual)
Study Completion Date
February 2003 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Johns Hopkins University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to test the utilization of incentive values (considerably lower than those typically used in research clinics) to motivate clients to attend treatment and initiate and sustain abstinence.
Detailed Description
The purpose of the proposed research is to implement and systematically evaluate, in community treatment settings, motivational incentive procedures that have been well researched and have proven efficacious in a variety of treatment research clinics. The study will determine if motivational incentives along with standard care therapy is more effective than standard therapy alone for the treatment of patients using cocaine or methamphetamine and entering a substance abuse treatment program.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
substance use disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Allocation
Randomized
Enrollment
390 (false)
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Behavior Therapy
Primary Outcome Measure Information:
Title
ASI
Title
Opioid and cocaine use
Title
AIDS risk behavior
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Recent admission to an opioid substitution (methadone maintenance) CTP. Completed at least 4 weeks of maintenance at time of study entry
Evidence of cocaine or methamphetamine use Minimum of one documented positive urine within 2 weeks of study entry. For those exiting a controlled environment, any stimulant use within two weeks of entering the controlled environment
Exclusion Criteria:
Unable to give informed consent (fails simple consent quiz)
Answers yes to question: Are you in recovery from gambling? That is, have you stopped gambling because of previous gambling problems?
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maxine Stitzer, Ph.D.
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aegis Medical Systems, Inc.
City
Bakersfield
State/Province
California
ZIP/Postal Code
93301 4709
Country
United States
Facility Name
Oasis Clinic
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20002
Country
United States
Facility Name
Glenwood Life Counseling Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21212
Country
United States
Facility Name
Lower Eastside Service Center (LESC)
City
New York
State/Province
New York
ZIP/Postal Code
10007
Country
United States
Facility Name
Greenwich House, Inc.
City
New York
State/Province
New York
ZIP/Postal Code
10014
Country
United States
Facility Name
ACT
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19141
Country
United States
Facility Name
Charleston Center
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29403
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics. - 1
We'll reach out to this number within 24 hrs